Inelastic Compression in Edema After Revascularization
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Jun 15, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to manage swelling (called edema) that can happen in the lower leg after surgery to improve blood flow, known as revascularization. Swelling can slow down healing and cause other problems, so finding effective treatments is important. The trial is looking at a type of compression bandage called inelastic compression, which applies steady pressure to the leg. Researchers want to see if this method is safe and does not negatively affect blood circulation in patients who have had surgery to restore blood flow.
To participate in the trial, individuals must be over 18 years old and have undergone specific types of bypass surgery to improve blood flow in their legs. They should also be enrolled in a health insurance plan. However, some people are not eligible, including those with certain severe health conditions, recent surgeries, or who are pregnant or breastfeeding. Participants will wear the inelastic compression bandages and will be monitored to ensure their safety and well-being during the study. This trial aims to provide new insights into managing post-surgery swelling effectively and safely.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. patients over 18 years of age
- • 2. arteriopathic patients requiring femoropopliteal revascularization by bypass surgery who have been revascularized
- • 3. signature of an informed consent
- • 4. person affiliated or beneficiary of a social security plan
- Exclusion Criteria:
- • 1. arterial bypasses under the leg or distal joints
- • 2. critical ischemia
- • 3. patients operated on for acute ischemia
- • 4. pregnant or breast-feeding women
- • 5. severe cardiac insufficiency
- • 5) severe peripheral neuropathy 6) allergies to the components of the tapes 7) persons deprived of liberty by judicial or administrative decision 8) persons under legal protection
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Patients applied
Trial Officials
PASCAL GIORDANA
Principal Investigator
Centre Hospitalier Universitaire de Nice
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported